Keyphrases
Prostate Cancer
100%
Tumor
34%
Metastasis
25%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
23%
Tumor Suppressor Gene
18%
Allelic Loss
17%
Prostate
16%
Homozygous Deletion
15%
Prostate Carcinoma
15%
Prostate Cancer Cells
14%
Methylation
13%
Cancer Tissue
12%
Primary Prostate Cancer
10%
GSTP1
10%
Loss of Heterozygosity
9%
Human Prostate Tissue
9%
Mutational Analysis
9%
Oncogenesis
9%
Genetic Modification
9%
Androgen Receptor
8%
Copy number Variation
8%
Hypermethylation
8%
Prostate Cancer Metastasis
7%
Prostate Cancer Progression
7%
Glycoprotein
7%
Primary Tumor
7%
DNA Methylation (DNAm)
7%
Advanced Prostate Cancer
7%
CpG Island
7%
Molecular Profiling
7%
Xenograft
6%
Hereditary Prostate Cancer
6%
Aggressive Prostate Cancer
6%
Polymerase Chain Reaction
6%
Tissue Specimens
6%
Prostate Cancer Risk
6%
Methylation Changes
5%
Metastatic Potential
5%
Prostate Tumor
5%
Human Cancer
5%
Normal Prostate
5%
Tumor Subtype
5%
Whole Genome
5%
In Cancer
5%
Oncogene
5%
Benign Prostatic Hyperplasia
5%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
5%
Prostatic Cancer
5%
Chromosome 8
5%
Biochemistry, Genetics and Molecular Biology
Tumor Suppressor Gene
27%
Cancer Cell
26%
Genomics
21%
Methylation
20%
Gene Mutation
17%
Carcinogenesis
12%
Evolution
11%
Gene Linkage
10%
Genetics
10%
Promoter Region
9%
Androgen Receptor
9%
Loss of Heterozygosity
9%
Exon
8%
DNA Methylation
8%
Polymerase Chain Reaction
8%
Microsatellite
7%
Messenger RNA
7%
Glycoprotein
7%
Yeast Artificial Chromosome
7%
GSTP1
7%
Allele
6%
Prostate-Specific Antigen
6%
CpG Island
6%
Germ Cell
6%
Oncogene
6%
Colon
6%
Chromosome 8
5%
Medicine and Dentistry
Prostate Cancer
62%
Metastatic Carcinoma
17%
Neoplasm
17%
Methylation
16%
Prostate Carcinoma
12%
Cancer Cell
11%
Malignant Neoplasm
9%
CpG Island
8%
Mutational Analysis
7%
Promoter Region
7%
Prostate Tissue
6%
Evolution
5%
Androgen
5%
Formaldehyde
5%
Cancer
5%
